BIOLOGICAL RESPONSE MODIFIERS ADVISORY COMMITTEE
April 6, 2001
Briefing Information
Session III
Proposal for Long-term Follow-up of Participants in Gene Transfer Clinical Trials pdf html
Session IV
Introduction - FDA Proposed Disclosure Rule, Dr. Philip Noguchi ppt html
Availability for Public Disclosure and Submission to FDA for Public Disclosure of Certain Data and Information Related to Human Gene Therapy or Xenotransplantation, Docket Number 00N-0989 pdf txt